Mithramycin selectively attenuates DNA-damage-induced neuronal cell death

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Death Research

Background:

• DNA damage is a key factor in neuronal loss and cognitive decline in conditions like TBI and chemotherapy side effects.
• Specificity protein 1 (Sp1) plays a role in regulating gene transcription involved in cell death pathways.

Purpose of the Study:

• To investigate the neuroprotective mechanisms of Mithramycin in DNA damage-induced neuronal cell death.
• To explore the role of Sp1 in p53-mediated apoptosis in neurons.

Main Methods:

• Utilized primary rat neurons in vitro and a mouse model of traumatic brain injury (TBI).
• Exposed neurons to DNA-damage-inducing chemotherapy drugs.
• Administered Mithramycin to assess its neuroprotective effects.
• Performed chromatin immunoprecipitation to analyze Sp1 and p53 binding to gene promoters.

Main Results:

• Mithramycin demonstrated significant neuroprotection against DNA-damage-dependent neuronal death by inhibiting apoptosis cascades downstream of ATM and p53.
• Mithramycin reduced the upregulation of pro-apoptotic BH3-only proteins and mitochondrial dysfunction.
• Chromatin immunoprecipitation revealed Mithramycin attenuates Sp1 binding to pro-apoptotic gene promoters, suggesting interference with p53 transactivation.

Conclusions:

• Sp1 is essential for p53-mediated transactivation of neuronal pro-apoptotic molecules.
• Mithramycin may serve as a therapeutic agent to attenuate neuronal cell death in conditions characterized by DNA damage and p53-dependent intrinsic apoptosis.